Mineralys (MLS-101-202): A RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, PARALLEL ARM, MULTI-CENTER, PHASE 2 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LORUNDROSTAT IN SUBJECTS WITH UNCONTROLLED HYPERTENSION ON A STANDARDIZED MEDICATION REGIMEN

The purpose of this clinical trial is to assess the blood pressure lowering effects of lorundrostat, taken once daily, in patients with high blood pressure.

Research

Patient

High Blood Pressure (Hypertension)

Active, not recruiting

217-545-7511

Related Profiles

John Flack

bpresearch@siumed.edu

Emily Starkey

https://clinicaltrials.gov/study/NCT05769608?term=MLS-101-202&rank=1

Cardiology